一个基于丝纤维蛋白支架的顺序药物递送系统,用于有效的软骨修复
Menglin Xiao1,2, Liangyan Sun1,3, Kang Wu1,2
1Department of Macromolecular Science, Department of Orthodontics, Multidisciplinary Consultant Center, Shanghai Stomatological Hospital & School of Stomatology, Fudan University, Shanghai, 200433, China.
Bioactive materials
|March 26, 2025
概括
这项研究开发了一种丝纤维蛋白支架,可以顺序释放药物来招募骨髓中介质干细胞 (BMSC) 并促进软骨修复. 脚手架有效地再生了大鼠的膝盖软骨缺陷,提供了一个有希望的组织工程解决方案.
科学领域:
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
- 再生医学是一种再生医学.
背景情况:
- 内源性软骨修复受到早期细胞不足和不完全分化的限制.
- 有效的 in-situ 软骨再生需要招募干细胞并促进它们的软骨生成.
- 丝纤维素 (SF) 支架为药物输送和组织工程提供了一个有前途的平台.
研究的目的:
- 开发一种无细胞,顺序递送药物的SF支架,用于在位地进行软骨再生.
- 招募内源性骨髓介质干细胞 (BMSCs) 并促进它们的冠状体差异化.
- 评估SF脚手架在修复软骨缺陷方面的有效性.
主要方法:
- 纤维素 (SF) 毛孔支架被制造出来,表面涂有BMSCs亲和性PFSSTKT (PFS).
- 基诱导剂卡尔托根因 (KGN) 和抗炎性德克萨米他 (DEX) 被装入SF支架,以便顺序释放.
- 在体外研究评估了BMSC的迁移和分化;在体内研究评估了老鼠的软骨缺陷再生.
主要成果:
- PFS在10天内迅速释放,而KGN和DEX在28天内释放.
- SF支架通过PFS和KGN释放促进了BMSCs的迁移和chondrogenic分化in vitro.
- 植入的SF支架成功地招募了内源性BMSC,并在大鼠中显著促进了膝关节软骨缺陷的现场再生.
结论:
- 开发了一种新的,环保的,全基于丝的连续药物输送系统.
- 功能性SF支架通过招募内源性干细胞并促进体生成,有效地促进地位软骨再生.
- 这种方法为治疗软骨缺陷提供了一个有希望的策略.
相关概念视频
01:27Fractures: Bone Repair
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
01:31Bone Remodeling and Repair
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.